MAP (mitogen-activated protein) 
. Our data on glucose corroborate those found by others. [ (Fig. 2 ). Glucose at a low concentration (3.0mM) had a small effect (Fig. 2) (Fig. 4) . The effects of both the phorbolester PMA and of glucose at two different concentrations are not affected by wortmannin (Fig. 4) . As shown in Figure 5 1 mM PMA has an acutely stimulating effect on MAP kinase which is abolished by a 22-hours pretreatment with l mM PMA. PMA, however, is not able to inhibit the stimulatory effect of other compounds on MAP kinase such as glucose, GRP, OT or GIP (Fig. 5 ).
Biological Effects (Insulin Secretion and Cell Proliferation)
It is interesting to know whether MAP kinase activity is necessary for specific biological effects. Insulin release is augmented by those concentrations of glucose, GRP, OT and GIP which are able to increase MAP kinase activity (Fig. 6) . The MEK inhibitor PD 098059, however, is not able to inhibit insulin release induced by either of the compounds (Fig. 6) . Cell 6B ). This is also the case when a substimulatory glucose concentration (3.0mM) was used ( Fig. 6C) which by itself has a small proliferative effect (Fig. 6B) [26'27] and CHO cells, I28] respectively.
Stimulating MAP kinase shows a biphasic pattern with two distinct maxima: after 2.5 min and 10min. Whereas the same time profile was found by some authors [29, 31 but not by others. [1, 21 This difference may be due to the fact that only the isoenzyme ERK1 was immunoprecipitated whereas in our and other studies both isoenzymes were estimated e.g., by the microtrap assay. Another reason for the biphasic profile may be that MAP kinase phosphatase I [31] dephosphorylates MAP kinase Activation of PKC is involved in the effects of GRP. [41] The oxytocin/vasopressin effect on MAP kinase is at least partially dependent on PKG. [38'43-46] [44] unless the cells had been transfected with cDNA of the vasopressinlb receptor. Our data with GRP are in line with the observation that GRP has proliferative effects in normal cells [52, 53] but not in carcinoma cells. [54] [3H]Thymidine incorporation was inhibited by the MEK inhibitor PD 098059 at 8.3mM glucose. Since the inhibition come down to the same level independent of the compound used, it is obvious that the glucose effect is inhibited. Additionally the proliferative effects of GIP and IGF-1 are inhibited even at low glucose (3.0mM). Since GIP is an important incretin its proliferative effect may be of clinical importance. Altogether the MEK inhibitor is effective in blocking glucose effects; when proliferation is stimulated by high glucose concentrations, the additional small effects of GRP, GIP or IGF-I cannot be blocked. The proliferative effect of these compound is only blocked when low glucose concentrations (3.0 mM) were used.
A scheme illustrating the points that are addressed in this paper is shown in Figure 8 . 
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